Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 551–600 of 1,127 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06985238	Stratagen Quantitative Prostate MRI Platform Pilot Study	recruiting	N/A	75	Stratagen Bio, Inc.INDUSTRY	1	Mar 6, 2026	clinicaltrials
NCT01181375	Predictive Assays In Cervix Cancer	active not recruiting	N/A	500	University Health Network, TorontoOTHER	1	Mar 5, 2026	clinicaltrials
NCT03853915